This inventor holds 2 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1978-1986.
Location History:
- Groebenzell, DE (1978)
- Bielefeld, DE (1986)
Company Filing History:
Years Active: 1978-1986
Title: The Innovations of Harald Tschesche
Introduction
Harald Tschesche is a notable inventor based in Groebenzell, Germany. He has made significant contributions to the field of proteinase inhibitors, holding 2 patents that showcase his innovative work. His research has implications in various biological and medical applications.
Latest Patents
Tschesche's latest patents include groundbreaking inventions. One patent focuses on homologues of aprotinin, which replace lysine with other amino acid moieties in position 15. This invention relates to methods for their preparation and their use as proteinase inhibitors. Another patent involves deamino derivatives of the kallikrein-trypsin inhibitor, characterized by specific amino acid compositions and protease inhibitory activities. These inventions highlight his expertise in biochemistry and protein engineering.
Career Highlights
Harald Tschesche has had a distinguished career, working at Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His role at Bayer has allowed him to collaborate with other experts in the field and contribute to innovative research and development.
Collaborations
Throughout his career, Tschesche has worked alongside notable colleagues such as Eugen Schnabel and Ernst Truscheit. These collaborations have further enriched his research and have led to advancements in the understanding of proteinase inhibitors.
Conclusion
Harald Tschesche's contributions to the field of proteinase inhibitors through his patents and collaborations demonstrate his significant impact on biochemistry. His work continues to influence research and applications in the life sciences.